New Haven, CT32 Active Studies

Myalgic Encephalomyelitis Clinical Trials in New Haven, CT

Find 32 actively recruiting myalgic encephalomyelitis clinical trials in New Haven, CT. Connect with local research sites and explore new treatment options.

32
Active Trials
24
Sponsors
105,737
Enrolling

Recruiting Myalgic Encephalomyelitis Studies in New Haven

About Myalgic Encephalomyelitis Clinical Trials in New Haven

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 32 myalgic encephalomyelitis clinical trials recruiting participants in New Haven, CT. These studies are seeking a combined 105,737 participants. Research is being sponsored by University of South Florida, Duke University, AstraZeneca and 21 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in New Haven — FAQ

Are there myalgic encephalomyelitis clinical trials in New Haven?

Yes, there are 32 myalgic encephalomyelitis clinical trials currently recruiting in New Haven, CT. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New Haven?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Haven research site will contact you about next steps.

Are clinical trials in New Haven free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Haven studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 32 active trials in New Haven are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated July 13, 2026 from ClinicalTrials.gov